The HCC biomarkers, Lens culinaris agglutinin fraction of AFP (AFP-L3) and des-gamma-carboxyprothrombin (DCP) with AFP, have been approved for surveillance in HCC but have not yet impacted disease management. Here, AFP is linked to hepatocellular carcinoma.